PETER M. CASTLEMAN - 17 Jun 2025 Form 3 Insider Report for Caris Life Sciences, Inc.

Role
Director
Signature
/s/ J. Russel Denton, Attorney-in-Fact
Issuer symbol
CAI on Nasdaq
Transactions as of
17 Jun 2025
Net transactions value
$0
Form type
3
Filing time
17 Jun 2025, 21:32:28 UTC
Previous filing
23 Jun 2025
Next filing
13 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CASTLEMAN PETER M Director C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING /s/ J. Russel Denton, Attorney-in-Fact 17 Jun 2025 0001239594

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CAI Common Stock 16,129 17 Jun 2025 Direct F1
holding CAI Common Stock 100,000 17 Jun 2025 By Family Trust
holding CAI Common Stock 25,000 17 Jun 2025 By CLS-PF-SPE, LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CAI Stock Option 17 Jun 2025 Common Stock 2,500 $18.60 Direct F3
holding CAI Series A Preferred Stock 17 Jun 2025 Common Stock 10,245,906 $0.000000 By CLS-PF-SPE, LLC F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 16,129 shares of Common Stock underlying restricted stock units which vest in accordance with the applicable grant agreement.
F2 CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE, LLC. Mr. Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
F3 The stock option is fully vested and exercisable.
F4 Each share of preferred stock will automatically convert into 0.25 shares of Common Stock of the Issuer, subject to adjustment in accordance with the certificate of formation, upon the closing of the initial public offering of the Issuer's Common Stock.

Remarks:

Exhibit 24 - Power of Attorney.